Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients

被引:36
作者
Anty, Rodolphe [1 ,2 ,3 ]
Tonohouan, M. [1 ]
Ferrari-Panaia, P. [4 ]
Piche, T. [2 ,3 ,5 ]
Pariente, A. [6 ]
Anstee, Q. M. [7 ]
Gual, P. [1 ,3 ]
Tran, A. [1 ,2 ,3 ]
机构
[1] Fac Med Nice, INSERM, U1065, Team 8,Hepat Complicat Obes, F-06034 Nice, France
[2] CHU Nice, Digest Ctr, Pole Reference Hepatite C, Hop Archet 2, F-06202 Nice 3, France
[3] Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France
[4] CHU Nice, Ctr Biol, F-06202 Nice 3, France
[5] Fac Med Nice, INSERM, Dept Immunol, Archet Hosp 1, F-06034 Nice, France
[6] Ctr Hosp Pau, Digest Ctr, Pau, France
[7] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY | 2014年 / 5卷
关键词
SUSTAINED VIROLOGICAL RESPONSE; D-BINDING PROTEIN; D-RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; LIVER DYSFUNCTION; GUT MICROBIOTA; D DEFICIENCY; FIBROSIS; DISEASE; MORTALITY;
D O I
10.1038/ctg.2014.6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Low levels of vitamin D are associated with a higher mortality in cirrhotic patients, but the role of this deficiency is still unknown. The purpose of this study was to assess the levels of vitamin D in cirrhotic patients with and without bacterial infection. METHODS: 25-hydroxy (25-OH) vitamin D was assessed by immunoassay in 88 patients hospitalized in our hepatology unit. RESULTS: The causes of cirrhosis were mainly alcohol (70%), hepatitis C (10%), or both (9%). Infections (n = 38) mainly included bacteriemia (21%), urinary tract infections (24%), and spontaneous bacterial peritonitis (29%). A severe deficiency in vitamin D (<10 ng/ml) was observed in 56.8% of patients. Infections were more frequent in patients with a severe deficiency compared with the others (54 vs. 29%, P = 0.02). A severe deficiency in vitamin D was a predictive factor of infection (odds ratio = 5.44 (1.35-21.97), P = 0.017) independently of the Child-Pugh score (odds ratio = 2.09 (1.47-2.97) P = 0.00004) and the C-reactive protein level (odds ratio = 1.03 (1.002-1.052), P = 0.03) in a logistic regression also including the alanine amino transferase (not significant). By a Cox regression analysis, only the presence of an infection was significantly associated with mortality (relative risk = 3.24 (1.20-8.76), P = 0.02) in a model also associating the Child-Pugh score (not significant) and the presence of a severe deficiency in vitamin D (not significant). CONCLUSIONS: Low levels of 25-OH vitamin D were independently associated with bacterial infections in cirrhotic patients. The impact of 25-OH vitamin D supplementation on the infection rate and death of cirrhotic patients should be assessed in randomized trials.
引用
收藏
页数:10
相关论文
共 58 条
  • [1] Relationships between blood levels of fat soluble vitamins and disease etiology and severity in adults awaiting liver transplantation
    Abbott-Johnson, Winsome
    Kerlin, Paul
    Clague, Alan
    Johnson, Helen
    Cuneo, Ross
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (09) : 1402 - 1410
  • [2] Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients
    Abu-Mouch, Saif
    Fireman, Zvi
    Jarchovsky, Jacob
    Zeina, Abdel-Rauf
    Assy, Nimer
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (47) : 5184 - 5190
  • [3] Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining Prognosis
    Arvaniti, Vasiliki
    D'Amico, Gennaro
    Fede, Giuseppe
    Manousou, Pinelopi
    Tsochatzis, Emmanuel
    Pleguezuelo, Maria
    Burroughs, Andrew Kenneth
    [J]. GASTROENTEROLOGY, 2010, 139 (04) : 1246 - +
  • [4] Vitamin D: modulator of the immune system
    Baeke, Femke
    Takiishi, Tatiana
    Korf, Hannelie
    Gysemans, Conny
    Mathieu, Chantal
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (04) : 482 - 496
  • [5] Altered profile of human gut microbiome is associated with cirrhosis and its complications
    Bajaj, Jasmohan S.
    Heuman, Douglas M.
    Hylemon, Phillip B.
    Sanyal, Arun J.
    White, Melanie B.
    Monteith, Pamela
    Noble, Nicole A.
    Unser, Ariel B.
    Daita, Kalyani
    Fisher, Andmorgan R.
    Sikaroodi, Masoumeh
    Gillevet, Patrick M.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (05) : 940 - 947
  • [6] Second Infections Independently Increase Mortality in Hospitalized Patients With Cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease (NACSELD) Experience
    Bajaj, Jasmohan S.
    O'Leary, Jacqueline G.
    Reddy, K. Rajender
    Wong, Florence
    Olson, Jody C.
    Subramanian, Ram M.
    Brown, Geri
    Noble, Nicole A.
    Thacker, Leroy R.
    Kamath, Patrick S.
    [J]. HEPATOLOGY, 2012, 56 (06) : 2328 - 2335
  • [7] Liver Vitamin D Receptor, CYP2R1, and CYP27A1 Expression: Relationship With Liver Histology and Vitamin D3 Levels in Patients With Nonalcoholic Steatohepatitis or Hepatitis C Virus
    Barchetta, Ilaria
    Carotti, Simone
    Labbadia, Giancarlo
    Gentilucci, Umberto Vespasiani
    Muda, Andrea Onetti
    Angelico, Francesco
    Silecchia, Gianfranco
    Leonetti, Frida
    Fraioli, Antonio
    Picardi, Antonio
    Morini, Sergio
    Cavallo, Maria Gisella
    [J]. HEPATOLOGY, 2012, 56 (06) : 2180 - 2187
  • [8] The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients
    Baur, Katharina
    Mertens, Joachim C.
    Schmitt, Johannes
    Iwata, Rika
    Stieger, Bruno
    Frei, Pascal
    Seifert, Burkhardt
    Ferrari, Heike A. Bischoff
    von Eckardstein, Arnold
    Muellhaupt, Beat
    Geier, Andreas
    [J]. ANTIVIRAL THERAPY, 2012, 17 (03) : 541 - 547
  • [9] Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin D Receptor (NR 1I1) variants on fibrosis progression rate in HCV patients
    Baur, Katharina
    Mertens, Joachim C.
    Schmitt, Johannes
    Iwata, Rika
    Stieger, Bruno
    Eloranta, Jyrki J.
    Frei, Pascal
    Stickel, Felix
    Dill, Michael T.
    Seifert, Burkhardt
    Ferrari, Heike A. Bischoff
    Von Eckardstein, Arnold
    Bochud, Pierre-Yves
    Muellhaupt, Beat
    Geier, Andreas
    [J]. LIVER INTERNATIONAL, 2012, 32 (04) : 635 - 643
  • [10] EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
    Beuers, Ulrich
    Boberg, Kirsten M.
    Chapman, Roger W.
    Chazouilleres, Olivier
    Invernizzi, Pietro
    Jones, David E. J.
    Lammert, Frank
    Pares, Albert
    Trauner, Michael
    [J]. JOURNAL OF HEPATOLOGY, 2009, 51 (02) : 237 - 267